ORNATINS - POTENT GLYCOPROTEIN-IIB-IIIA ANTAGONISTS AND PLATELET-AGGREGATION INHIBITORS FROM THE LEECH PLACOBDELLA-ORNATA

被引:78
|
作者
MAZUR, P
HENZEL, WJ
SEYMOUR, JL
LAZARUS, RA
机构
[1] GENENTECH INC, DEPT PROT ENGN, San Francisco, CA 94080 USA
[2] COLUMBIA UNIV, DEPT CHEM, NEW YORK, NY 10027 USA
[3] GENENTECH INC, DEPT PROT CHEM, San Francisco, CA USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1991年 / 202卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1991.tb16472.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purification and characterization of six isoforms of ornatin, potent glycoprotein IIb-IIIa (GP IIb-IIIa) antagonists and platelet aggregation inhibitors are described. These isoforms were purified from whole leech homogenates of the leech Placobdella ornata, a North American leech commonly known as the turtle leech, by trichloroacetic acid precipitation, Sephadex G-50 size exclusion chromatography, GP IIb-IIIa affinity chromatography, and C18 reverse-phase HPLC. Each of the five completely sequenced isoforms, which range from 41 to 52 residues in length, contains the Arg-Gly-Asp (RGD) sequence, a common recognition sequence in adhesion proteins, as well as 6 cysteine residues; the positions of both of these features are conserved in the primary sequences. The amino acid sequences of ornatin isoforms B, C, D, and E are highly conserved, whereas ornatin A2 and A3 are less similar and lack 9 residues at the N-terminus. The ornatins are approximately 40% identical with decorsin, a GP IIb-IIIa antagonist isolated from the leech Macrobdella decora [Seymour, J. L., Henzel, W. J., Nevins, B., Stults, J. T. & Lazarus, R. A. (1990) J. Biol. Chem. 265, 10143-10147]; furthermore, the RGD sequence and 5 out of 6 cysteine residues are maintained in the same relative positions in both decorsin and ornatin. The ornatin isoforms do not exhibit significant similarity to any members of the snake-venom-derived family of GP IIb-IIIa antagonists [Dennis, M. S., Henzel, W. J., Pitti, R. M., Lipari, M. T., Napier, M. A., Deisher, T. A., Bunting, S. & Lazarus, R. A. (1990) Proc. Natl Acad. Sci. USA 87, 2471-2475] except in the RGD region of these proteins. The ornatin isoforms inhibit the binding of GP IIb-IIIa to immobilized fibrinogen with IC50 values ranging over 2.9-5.3 nM; ornatin isoforms A2, C, and E inhibit ADP-induced human platelet aggregation with IC50 values of about 130, 280, and 440 nM, respectively.
引用
收藏
页码:1073 / 1082
页数:10
相关论文
共 50 条
  • [41] Discovery of novel antagonists of glycoprotein IIb/IIIa-mediated platelet aggregation through virtual screening
    Wang, Yawen
    Zhao, Yang
    Sun, Rui
    Kong, Wanjun
    Wang, Bing
    Yang, Guangde
    Li, Yiping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) : 1249 - 1253
  • [42] INHIBITION OF PLATELET FC-RECEPTOR-DEPENDENT AGGREGATION BY A MONOCLONAL-ANTIBODY AGAINST THE GLYCOPROTEIN-IIB-IIIA COMPLEX
    VINOGRADOV, DV
    VLASIK, TN
    AGAFONOVA, OG
    VASILEV, SA
    LAGUTINA, NY
    MAKAROV, VA
    BERNDT, M
    MAZUROV, AV
    BIOCHEMISTRY-MOSCOW, 1991, 56 (05) : 532 - 539
  • [43] In vitro effects of the glycoprotein IIb/IIIa receptor antagonists abciximab and eptifibatide on platelet aggregation in healthy cats
    Magee, Aliya N.
    Hogan, Daniel E.
    Sederquist, Kimberly A.
    Durham, Jaylyn A.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2014, 75 (03) : 309 - 312
  • [44] Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIbβ3) inhibitors
    Peter, K
    Schwarz, M
    Ylänne, J
    Kohler, B
    Moser, M
    Nordt, T
    Salbach, P
    Kübler, W
    Bode, C
    BLOOD, 1998, 92 (09) : 3240 - 3249
  • [45] Analysis of the potent platelet glycoprotein IIb-IIIa antagonist from natural sources
    Kang, IC
    Kim, DS
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 31 (05): : 515 - 518
  • [46] A MONOCLONAL-ANTIBODY TO THE GLYCOPROTEIN IIB/IIIA COMPLEX INHIBITS RABBIT PLATELET-AGGREGATION BOTH INVITRO AND INVIVO
    AZRIN, MA
    TODD, MB
    PAWASHE, A
    BACH, R
    KONIGSBERG, W
    EZEKOWITZ, MD
    CLINICAL RESEARCH, 1990, 38 (02): : A367 - A367
  • [47] INCREASED SURFACE EXPRESSION OF THE MEMBRANE GLYCOPROTEIN IIB/IIIA COMPLEX INDUCED BY PLATELET ACTIVATION - RELATIONSHIP TO THE BINDING OF FIBRINOGEN AND PLATELET-AGGREGATION
    NIIYA, K
    HODSON, E
    BADER, R
    BYERSWARD, V
    KOZIOL, JA
    PLOW, EF
    RUGGERI, ZM
    BLOOD, 1987, 70 (02) : 475 - 483
  • [48] Platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists derived from amidinoindoles.
    Sall, DJ
    Arfsten, AE
    Berry, DR
    Denney, ML
    Harms, CS
    McCowan, JR
    Ray, JK
    Scarborough, RM
    Um, SL
    Utterback, BG
    Jakubowski, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) : 81 - 86
  • [49] THE THIENOPYRIDINE PCR-4099 SELECTIVELY INHIBITS ADP-INDUCED PLATELET-AGGREGATION AND FIBRINOGEN BINDING WITHOUT MODIFYING THE MEMBRANE GLYCOPROTEIN-IIB-IIIA COMPLEX IN RAT AND IN MAN
    GACHET, C
    STIERLE, A
    CAZENAVE, JP
    OHLMANN, P
    LANZA, F
    BOULOUX, C
    MAFFRAND, JP
    BIOCHEMICAL PHARMACOLOGY, 1990, 40 (02) : 229 - 238
  • [50] Platelet glycoprotein IIb/IIIa antagonists: Lessons learned from clinical trials and future directions
    Leclerc, JR
    CRITICAL CARE MEDICINE, 2002, 30 (05) : S332 - S340